REGENERON PHARMACEUTICALS, INC. 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
RP REGENERON PHARMACEUTICALS, INC. | Institutional Filer | ▲ 270.10% | $177.2M | 3 |
Current Portfolio Holdings
Showing all 3 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | No Ticker | Parabilis Medicines, Inc. | — | 4.2M | $114.0M | 64.35% |
| 2 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 3.7M | $62.7M | 35.35% |
| 3 | ACET | Adicet Bio, Inc. | Healthcare | 61K | $523K | 0.30% |
Showing 1 to 3 of 3 holdings